https://health.economictimes.indiatimes.com/news/pharma/chinas-cansino-seeks-more-vaccine-contracts-after-astrazenca-deal/103250671
Miyoung Kim: China's CanSino seeks more vaccine contracts after AstraZenca deal, ETHealthworld
Miyoung Kim: CanSino begun researching mRNA technology in 2018 and has built a facility in Shanghai that can produce up to 200 million doses a year, giving it...